Creative Financial Designs Inc Eli Lilly & CO Transaction History

Creative Financial Designs Inc

$1.11 Billion
Q2 2024

A detailed history of Creative Financial Designs Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Creative Financial Designs Inc holds 16,014 shares of LLY stock, worth $14.1 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares

16,014

Previous 15,190 5.42%

Holding current value

$14.1 Million

Previous $11.8 Million 22.69%

% of portfolio

1.31%

Previous 1.13%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$724.87 - $909.04 $597,292 - $749,048	824 Added 5.42%	16,014 $14.5 Million
Q1 2024 May 01, 2024	BUY	$592.2 - $792.28 $300,837 - $402,478	508 Added 3.46%	15,190 $11.8 Million
Q4 2023 Jan 10, 2024	SELL	$525.19 - $619.13 $683,272 - $805,488	-1,301 Reduced 8.14%	14,682 $8.56 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $41,731 - $57,532	-96 Reduced 0.6%	15,983 $8.58 Million
Q2 2023 Jul 26, 2023	SELL	$350.74 - $468.98 $366,172 - $489,615	-1,044 Reduced 6.1%	16,079 $7.54 Million
Q1 2023 Apr 25, 2023	BUY	$310.63 - $364.82 $435,503 - $511,477	1,402 Added 8.92%	17,123 $5.88 Million
Q4 2022 Feb 01, 2023	SELL	$321.55 - $374.67 $331,518 - $386,284	-1,031 Reduced 6.15%	15,721 $5.75 Million
Q3 2022 Nov 01, 2022	SELL	$296.48 - $337.87 $72,044 - $82,102	-243 Reduced 1.43%	16,752 $5.42 Million
Q2 2022 Aug 01, 2022	SELL	$278.73 - $327.27 $145,775 - $171,162	-523 Reduced 2.99%	16,995 $5.51 Million
Q1 2022 Apr 15, 2022	BUY	$234.69 - $291.66 $2.9 Million - $3.6 Million	12,339 Added 238.25%	17,518 $5.02 Million
Q4 2021 Jan 26, 2022	BUY	$224.85 - $279.04 $114,448 - $142,031	509 Added 10.9%	5,179 $1.43 Million
Q3 2021 Oct 08, 2021	SELL	$221.6 - $272.71 $52,740 - $64,904	-238 Reduced 4.85%	4,670 $1.08 Million
Q2 2021 Jul 27, 2021	BUY	$180.55 - $233.54 $234,715 - $303,602	1,300 Added 36.03%	4,908 $1.13 Million
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $36,150 - $46,798	-220 Reduced 5.75%	3,608 $674,000
Q4 2020 Jan 08, 2021	BUY	$130.46 - $172.63 $13,698 - $18,126	105 Added 2.82%	3,828 $646,000
Q3 2020 Oct 06, 2020	BUY	$146.22 - $169.13 $1,169 - $1,353	8 Added 0.22%	3,723 $551,000
Q2 2020 Jul 23, 2020	BUY	$136.42 - $164.18 $394,935 - $475,301	2,895 Added 353.05%	3,715 $610,000
Q1 2020 Apr 22, 2020	SELL	$119.05 - $147.35 $41,429 - $51,277	-348 Reduced 29.79%	820 $114,000
Q4 2019 Jan 17, 2020	SELL	$106.92 - $132.43 $13,365 - $16,553	-125 Reduced 9.67%	1,168 $154,000
Q3 2019 Oct 23, 2019	BUY	$106.79 - $116.16 $12,280 - $13,358	115 Added 9.76%	1,293 $138,000
Q1 2019 Apr 23, 2019	BUY	$111.31 - $131.02 $118,879 - $139,929	1,068 Added 970.91%	1,178 $153,000
Q3 2018 Nov 02, 2018	BUY	$85.86 - $107.31 $858 - $1,073	10 Added 10.0%	110 $12,000
Q2 2018 Jul 13, 2018	SELL	$75.7 - $86.88 $30,280 - $34,752	-400 Reduced 80.0%	100 $9,000
Q4 2017 May 02, 2018	BUY	$81.94 - $87.89 $29,252 - $31,376	357 Added 249.65%	500 $42,000
Q3 2017 May 02, 2018	BUY	$77.07 - $85.54 $77 - $85	1 Added 0.7%	143 $12,000
Q2 2017 May 02, 2018	BUY	N/A	42 Added 42.0%	142 $12,000
Q4 2016 Mar 14, 2018	BUY	N/A	100	100 $7,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

News

Stay updated on Creative Financial Designs Inc with notifications on news.

Account

Creative Financial Designs Inc Eli Lilly & CO Transaction History